Clinical study transparency programs are necessary for companies looking to disclose data and fully comply with state and federal regulations. Why else should your company create a transparency program? Join Darshan Kulkarni as he talks with guest...
Many ethical concerns are raised after patients die in clinical trials. Once a patient dies, what happens to their consent? Join Darshan Kulkarni as he talks with professor of philosophy Peter Koch about the rights patients have after death. Plus...
In this follow-up to our recent discussion on clinical trial enrollment, we will discuss how an emphasis on patient centricity will help clinical trial researchers overcome a few challenges when trying to enroll in research subjects.
